Roger L. Albin - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Basal Ganglia

264 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Zhou Z, Müller MLTM, Kanel P, Chua J, Kotagal V, Kaufer DI, Albin RL, Frey KA, Bohnen NI. Apathy rating scores and β-amyloidopathy in Parkinson disease patients at risk for cognitive decline. Neurology. PMID 31732566 DOI: 10.1212/WNL.0000000000008683  0.52
2019 Bohnen NI, Kanel P, Zhou Z, Koeppe RA, Frey KA, Dauer WT, Albin RL, Müller MLTM. Cholinergic system changes of falls and freezing of gait in Parkinson disease. Annals of Neurology. PMID 30720884 DOI: 10.1002/ana.25430  0.52
2018 Albin RL, Bohnen NI, Muller ML, Dauer WT, Sarter M, Frey KA, Koeppe RA. Regional Vesicular Acetylcholine Transporter Distribution in Human Brain: A [ F]Fluoroethoxybenzovesamicol Positron Emission Tomography Study. The Journal of Comparative Neurology. PMID 30255936 DOI: 10.1002/cne.24541  0.52
2018 Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, Müller MLTM, Bohnen NI. Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [F]-FEOBV. Molecular Psychiatry. PMID 30082840 DOI: 10.1038/s41380-018-0130-5  0.52
2018 Kotagal V, Spino C, Bohnen NI, Koeppe RA, Albin RL. Serotonin, beta-amyloid, and cognition in Parkinson disease. Annals of Neurology. PMID 29665066 DOI: 10.1002/ana.25236  0.52
2017 Bohnen NI, Haugen J, Ridder A, Kotagal V, Albin RL, Frey KA, Müller MLTM. Color discrimination errors associate with axial motor impairments in Parkinson's disease. Movement Disorders Clinical Practice. 4: 864-869. PMID 29226177 DOI: 10.1002/mdc3.12527  0.52
2017 Albin RL, Minderovic C, Koeppe RA. Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome. Eneuro. 4. PMID 28791334 DOI: 10.1523/ENEURO.0178-17.2017  0.52
2017 Kotagal V, Bohnen NI, Müller ML, Frey KA, Albin RL. Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson Disease. Journal of Parkinson's Disease. PMID 28106566 DOI: 10.3233/JPD-160985  0.52
2016 Zhu F, Panwar B, Dodge HH, Li H, Hampstead BM, Albin RL, Paulson HL, Guan Y. COMPASS: A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's disease. Scientific Reports. 6: 34567. PMID 27703197 DOI: 10.1038/srep34567  0.56
2016 Albin RL, Frey KA. Reverse Translation in Parkinson Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27151982 DOI: 10.2967/jnumed.116.175257  0.52
2016 Wehner AB, Milen AA, Albin RL, Pierchala BA. The p75 Neurotrophin Receptor Augments Survival Signaling in the Striatum of Pre-Symptomatic Q175(WT/HD) mice. Neuroscience. PMID 26947127 DOI: 10.1016/j.neuroscience.2016.02.069  0.96
2016 Haugen J, Müller ML, Kotagal V, Albin RL, Koeppe RA, Scott PJ, Frey KA, Bohnen NI. Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 26911386 DOI: 10.1007/s00702-016-1524-7  0.96
2016 Kumar A, Zhang J, Tallaksen-Greene S, Crowley MR, Crossman DK, Morton AJ, van Groen T, Kadish I, Albin RL, Lesort M, Detloff PJ. Allelic Series of Huntington's Disease Knock-in Mice Reveals Expression Discorrelates. Human Molecular Genetics. PMID 26908599 DOI: 10.1093/hmg/ddw040  0.96
2016 Ringman JM, Monsell S, Ng DW, Zhou Y, Nguyen A, Coppola G, Van Berlo V, Mendez MF, Tung S, Weintraub S, Mesulam MM, Bigio EH, Gitelman DR, Fisher-Hubbard AO, Albin RL, et al. Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database. Journal of Neuropathology and Experimental Neurology. PMID 26888304 DOI: 10.1093/jnen/nlv028  0.96
2015 Albin RL, Miller RA. Mini-review: Retarding aging in murine genetic models of neurodegeneration. Neurobiology of Disease. 85: 73-80. PMID 26477301 DOI: 10.1016/j.nbd.2015.10.014  0.96
2015 Albin RL. Out of one mutation, many Huntington's disease effects. The Lancet. Neurology. 14: 1071-2. PMID 26466773 DOI: 10.1016/S1474-4422(15)00247-1  0.96
2015 Shah N, Frey KA, L T M Müller M, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Bohnen NI. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26380951 DOI: 10.1002/mds.26369  0.52
2015 Snider J, Müller ML, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Albin RL, Bohnen NI. Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degeneration. Parkinsonism & Related Disorders. PMID 26330028 DOI: 10.1016/j.parkreldis.2015.08.027  0.52
2015 Albin RL, Fisher-Hubbard A, Shanmugasundaram K, Koeppe RA, Burke JF, Camelo-Piragua S, Lieberman AP, Giordani B, Frey KA. Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography dementia classifications. Annals of Neurology. PMID 26183692 DOI: 10.1002/ana.24481  0.96
2015 Albin RL, Burke JF. Potential trade-offs in treatment of premanifest Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1319-23. PMID 26173644 DOI: 10.1002/mds.26318  0.96
2015 Zeng L, Wang B, Merillat SA, Minakawa E, Perkins MD, Ramani B, Tallaksen-Greene SJ, Costa MD, Albin RL, Paulson HL. Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3. Neurobiology of Disease. PMID 26141599 DOI: 10.1016/j.nbd.2015.06.017  0.96
2015 Kotagal V, Bohnen NI, Müller ML, Koeppe RA, Frey KA, Langa KM, Albin RL. Educational attainment and motor burden in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1143-7. PMID 26096339 DOI: 10.1002/mds.26272  0.52
2015 Müller ML, Albin RL, Bohnen NI, Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study. Neurology. 84: 2292. PMID 26033339 DOI: 10.1212/WNL.0000000000001654  0.96
2015 Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Müller ML, Albin RL, Frey KA. Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 928-35. PMID 25879534 DOI: 10.1002/mds.26191  0.52
2015 Cary BP, Brooks AF, Fawaz MV, Shao X, Desmond TJ, Carpenter GM, Sherman P, Quesada CA, Albin RL, Scott PJ. Targeting Metal-Aβ Aggregates with Bifunctional Radioligand [(11)C]L2-b and a Fluorine-18 Analogue [(18)F]FL2-b. Acs Medicinal Chemistry Letters. 6: 112-116. PMID 25705326 DOI: 10.1021/ml500413d  0.96
2015 Kucinski A, Albin RL, Lustig C, Sarter M. Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss. Behavioural Brain Research. 282: 155-64. PMID 25595423 DOI: 10.1016/j.bbr.2015.01.012  0.96
2015 Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Albin RL, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/jamaneurol.2014.2157  0.96
2015 Bohnen NI, Albin RL, Müller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. Jama Neurology. 72: 194-200. PMID 25506674 DOI: 10.1001/jamaneurol.2014.2757  0.96
2015 Dayalu P, Albin RL. Huntington disease: pathogenesis and treatment. Neurologic Clinics. 33: 101-14. PMID 25432725 DOI: 10.1016/j.ncl.2014.09.003  0.96
2015 Kotagal V, Langa KM, Plassman BL, Fisher GG, Giordani BJ, Wallace RB, Burke JR, Steffens DC, Kabeto M, Albin RL, Foster NL. Factors associated with cognitive evaluations in the United States. Neurology. 84: 64-71. PMID 25428689 DOI: 10.1212/WNL.0000000000001096  0.96
2015 Müller ML, Bohnen NI, Kotagal V, Scott PJ, Koeppe RA, Frey KA, Albin RL. Clinical markers for identifying cholinergic deficits in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 269-73. PMID 25393613 DOI: 10.1002/mds.26061  0.52
2014 Burke JF, Langa KM, Hayward RA, Albin RL. Modeling test and treatment strategies for presymptomatic Alzheimer disease. Plos One. 9: e114339. PMID 25474698 DOI: 10.1371/journal.pone.0114339  0.96
2014 Bohnen NI, Kotagal V, Müller ML, Koeppe RA, Scott PJ, Albin RL, Frey KA, Petrou M. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease. Parkinsonism & Related Disorders. 20: 1394-8. PMID 25454317 DOI: 10.1016/j.parkreldis.2014.10.008  0.96
2014 Tallaksen-Greene SJ, Sadagurski M, Zeng L, Mauch R, Perkins M, Banduseela VC, Lieberman AP, Miller RA, Paulson HL, Albin RL. Differential effects of delayed aging on phenotype and striatal pathology in a murine model of Huntington disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 15658-68. PMID 25411494 DOI: 10.1523/JNEUROSCI.1830-14.2014  0.96
2014 Albin RL. Nourish the roots while picking the fruit. Neurology. 83: 1473-5. PMID 25313377 DOI: 10.1212/01.wnl.0000455934.19444.86  0.96
2014 Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Albin RL, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/jamaneurol.2014.1491  0.96
2014 Dodge HH, Zhu J, Harvey D, Saito N, Silbert LC, Kaye JA, Koeppe RA, Albin RL. Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 690-703. PMID 25022534 DOI: 10.1016/j.jalz.2014.04.513  0.96
2014 Pappas SS, Leventhal DK, Albin RL, Dauer WT. Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits. Current Topics in Developmental Biology. 109: 97-169. PMID 24947237 DOI: 10.1016/B978-0-12-397920-9.00001-9  0.96
2014 Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Constantine GM, Scott PJ, Albin RL, Müller ML. Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1118-24. PMID 24909584 DOI: 10.1002/mds.25929  0.96
2014 Fawaz MV, Brooks AF, Rodnick ME, Carpenter GM, Shao X, Desmond TJ, Sherman P, Quesada CA, Hockley BG, Kilbourn MR, Albin RL, Frey KA, Scott PJ. High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection. Acs Chemical Neuroscience. 5: 718-30. PMID 24896980 DOI: 10.1021/cn500103u  0.96
2014 Bohnen N, Sarter M, Muller M, Dauer W, Albin R. Author response. Neurology. 82: 1568-9. PMID 24895748 DOI: 10.1212/WNL.0000000000000607  0.96
2014 Kotagal V, Albin RL, Müller ML, Koeppe RA, Studenski S, Frey KA, Bohnen NI. Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 69: 1569-75. PMID 24864306 DOI: 10.1093/gerona/glu070  0.52
2014 Sarter M, Albin RL, Kucinski A, Lustig C. Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function. Experimental Neurology. 257: 120-9. PMID 24805070 DOI: 10.1016/j.expneurol.2014.04.032  0.96
2014 Albin RL, Dauer WT. Magic shotgun for Parkinson's disease? Brain : a Journal of Neurology. 137: 1274-5. PMID 24771397 DOI: 10.1093/brain/awu076  0.96
2014 Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease. Neurology. 82: 1514-20. PMID 24682965 DOI: 10.1212/WNL.0000000000000356  0.96
2014 Postuma RB, Albin RL. Placebo: from belief to movement. Neurology. 82: 1390-1. PMID 24658928 DOI: 10.1212/WNL.0000000000000348  0.96
2014 Petrou M, Frey KA, Kilbourn MR, Scott PJ, Raffel DM, Bohnen NI, Müller ML, Albin RL, Koeppe RA. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 396-404. PMID 24481024 DOI: 10.2967/jnumed.113.124792  0.96
2014 Younes L, Ratnanather JT, Brown T, Aylward E, Nopoulos P, Johnson H, Magnotta VA, Paulsen JS, Margolis RL, Albin RL, Miller MI, Ross CA. Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Human Brain Mapping. 35: 792-809. PMID 23281100 DOI: 10.1002/hbm.22214  0.96
2014 Bohnen NI, Müller ML, Dauer WT, Albin RL. Parkinsons disease: What role do pedunculopontine cholinergic neurons play? Future Neurology. 9: 5-8. DOI: 10.2217/fnl.13.61  0.96
2014 Snider J, Albin RL. Structural causes of chorea Chorea : Causes and Management. 279-294. DOI: 10.1007/978-1-4471-6455-5_16  0.96
2013 Zeng L, Tallaksen-Greene SJ, Wang B, Albin RL, Paulson HL. The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease. Journal of Huntington's Disease. 2: 201-15. PMID 24683430 DOI: 10.3233/JHD-130058  0.96
2013 Hockley BG, Stewart MN, Sherman P, Quesada C, Kilbourn MR, Albin RL, Scott PJ. (-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical use. Journal of Labelled Compounds & Radiopharmaceuticals. 56: 595-9. PMID 24285235 DOI: 10.1002/jlcr.3069  0.96
2013 Chung S, Bohnen NI, Albin RL, Frey KA, Müller ML, Chervin RD. Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 9: 1131-7. PMID 24235893 DOI: 10.5664/jcsm.3150  0.96
2013 Kucinski A, Paolone G, Bradshaw M, Albin RL, Sarter M. Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 16522-39. PMID 24133257 DOI: 10.1523/JNEUROSCI.2545-13.2013  0.96
2013 Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Müller ML. Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology. 81: 1611-6. PMID 24078735 DOI: 10.1212/WNL.0b013e3182a9f558  0.96
2013 Müller ML, Albin RL, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Bohnen NI. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. Brain : a Journal of Neurology. 136: 3282-9. PMID 24056537 DOI: 10.1093/brain/awt247  0.96
2013 Albin RL, Burke JF, Koeppe RA, Giordani B, Gilman S, Frey KA. Assessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 887-93. PMID 23572495 DOI: 10.2967/jnumed.112.112599  0.96
2013 Meisler MH, Grant AE, Jones JM, Lenk GM, He F, Todd PK, Kamali M, Albin RL, Lieberman AP, Langenecker SA, McInnis MG. C9ORF72 expansion in a family with bipolar disorder. Bipolar Disorders. 15: 326-32. PMID 23551834 DOI: 10.1111/bdi.12063  0.96
2013 Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Gender differences in cholinergic and dopaminergic deficits in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 1421-4. PMID 23532360 DOI: 10.1007/s00702-013-1013-1  0.96
2013 Piehowski PD, Petyuk VA, Orton DJ, Xie F, Moore RJ, Ramirez-Restrepo M, Engel A, Lieberman AP, Albin RL, Camp DG, Smith RD, Myers AJ. Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis. Journal of Proteome Research. 12: 2128-37. PMID 23495885 DOI: 10.1021/pr301146m  0.96
2013 Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism & Related Disorders. 19: 522-6. PMID 23462483 DOI: 10.1016/j.parkreldis.2013.01.016  0.96
2013 Antonini A, Albin RL. Dopaminergic treatment and nonmotor features of Parkinson disease: the horse lives. Neurology. 80: 784-5. PMID 23365050 DOI: 10.1212/WNL.0b013e318285c16d  0.96
2013 Müller ML, Frey KA, Petrou M, Kotagal V, Koeppe RA, Albin RL, Bohnen NI. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 296-301. PMID 23239424 DOI: 10.1002/mds.25213  0.96
2013 Müller MLTM, Albin RL, Bohnen NI. Association of cardinal motor symptoms with region-specific dopamine transporter activity in mild to moderate parkinson's disease European Neurological Journal. 4.  0.96
2012 Shao X, Carpenter GM, Desmond TJ, Sherman P, Quesada CA, Fawaz M, Brooks AF, Kilbourn MR, Albin RL, Frey KA, Scott PJ. Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles. Acs Medicinal Chemistry Letters. 3: 936-41. PMID 24900410 DOI: 10.1021/ml300216t  0.96
2012 Kotagal V, Albin RL, Müller ML, Bohnen NI. Clinical features of Parkinson disease when onset of diabetes came first: a case-control study. Neurology. 79: 1835-6; author reply. PMID 23251922  0.96
2012 Whitcomb DC, LaRusch J, Krasinskas AM, Klei L, Smith JP, Brand RE, Neoptolemos JP, Lerch MM, Tector M, Sandhu BS, Guda NM, Orlichenko L, Alkaade S, Amann ST, et al. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nature Genetics. 44: 1349-54. PMID 23143602 DOI: 10.1038/ng.2466  0.96
2012 Zolov SN, Bridges D, Zhang Y, Lee WW, Riehle E, Verma R, Lenk GM, Converso-Baran K, Weide T, Albin RL, Saltiel AR, Meisler MH, Russell MW, Weisman LS. In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. Proceedings of the National Academy of Sciences of the United States of America. 109: 17472-7. PMID 23047693 DOI: 10.1073/pnas.1203106109  0.96
2012 Kotagal V, Bohnen NI, Müller ML, Koeppe RA, Frey KA, Albin RL. Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease. Archives of Neurology. 69: 1628-31. PMID 22964894 DOI: 10.1001/archneurol.2012.764  0.96
2012 Petrou M, Bohnen NI, Müller ML, Koeppe RA, Albin RL, Frey KA. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology. 79: 1161-7. PMID 22933741 DOI: 10.1212/WNL.0b013e3182698d4a  0.96
2012 Vitvitsky VM, Garg SK, Keep RF, Albin RL, Banerjee R. Na+ and K+ ion imbalances in Alzheimer's disease. Biochimica Et Biophysica Acta. 1822: 1671-81. PMID 22820549 DOI: 10.1016/j.bbadis.2012.07.004  0.96
2012 Lelieveld IM, Müller ML, Bohnen NI, Koeppe RA, Chervin RD, Frey KA, Albin RL. The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study. Plos One. 7: e40166. PMID 22792235 DOI: 10.1371/journal.pone.0040166  0.96
2012 Albin RL, Dauer WT. Parkinson syndrome. Heterogeneity of etiology; heterogeneity of pathogenesis? Neurology. 79: 202-3. PMID 22722622 DOI: 10.1212/WNL.0b013e31825dd3d0  0.96
2012 Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, Frey KA. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 1609-17. PMID 22569194 DOI: 10.1038/jcbfm.2012.60  0.96
2012 Andreev VP, Petyuk VA, Brewer HM, Karpievitch YV, Xie F, Clarke J, Camp D, Smith RD, Lieberman AP, Albin RL, Nawaz Z, El Hokayem J, Myers AJ. Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains. Journal of Proteome Research. 11: 3053-67. PMID 22559202 DOI: 10.1021/pr3001546  0.96
2012 Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, ... ... Albin RL, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Human Molecular Genetics. 21: 3500-12. PMID 22556362 DOI: 10.1093/hmg/dds161  0.96
2012 Kotagal V, Albin RL, Müller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Annals of Neurology. 71: 560-8. PMID 22522445 DOI: 10.1002/ana.22691  0.96
2012 Bakulski KM, Dolinoy DC, Sartor MA, Paulson HL, Konen JR, Lieberman AP, Albin RL, Hu H, Rozek LS. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. Journal of Alzheimer's Disease : Jad. 29: 571-88. PMID 22451312 DOI: 10.3233/JAD-2012-111223  0.96
2011 Bohnen NI, Albin RL, Müller ML, Chou K. Advances in Therapeutic Options for Gait and Balance in Parkinson's Disease. Us Neurology. 7: 100-108. PMID 24348751  0.96
2011 Prust M, Wang J, Morizono H, Messing A, Brenner M, Gordon E, Hartka T, Sokohl A, Schiffmann R, Gordish-Dressman H, Albin R, Amartino H, Brockman K, Dinopoulos A, Dotti MT, et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology. 77: 1287-94. PMID 21917775 DOI: 10.1212/WNL.0b013e3182309f72  0.96
2011 Burke JF, Albin RL. Do neurologists make a difference in Parkinson disease care? Neurology. 77: e52-3. PMID 21876194 DOI: 10.1212/WNL.0b013e31822f48fb  0.96
2011 Burke JF, Albin RL. Do neurologists make a difference in Parkinson disease care? Neurology. 77: 814-5. PMID 21832212 DOI: 10.1212/WNL.0b013e31822b0118  0.96
2011 Tallaksen-Greene SJ, Albin RL. Treating mouse models of Huntington disease. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 2373-4. PMID 21814186 DOI: 10.1038/npp.2011.158  0.96
2011 Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nature Genetics. 43: 699-705. PMID 21685912 DOI: 10.1038/ng.859  0.96
2011 Bohnen NI, Müller ML, Zarzhevsky N, Koeppe RA, Bogan CW, Kilbourn MR, Frey KA, Albin RL. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain : a Journal of Neurology. 134: 2358-65. PMID 21653540 DOI: 10.1093/brain/awr139  0.96
2011 Hammers D, Spurgeon E, Ryan K, Persad C, Heidebrink J, Barbas N, Albin R, Frey K, Darby D, Giordani B. Reliability of repeated cognitive assessment of dementia using a brief computerized battery American Journal of Alzheimer's Disease and Other Dementias. 26: 326-333. PMID 21636581 DOI: 10.1177/1533317511411907  0.96
2011 Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 848-55. PMID 21571793 DOI: 10.2967/jnumed.111.089946  0.96
2011 Burke JF, Albin RL, Koeppe RA, Giordani B, Kilbourn MR, Gilman S, Frey KA. Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography. Brain : a Journal of Neurology. 134: 1647-57. PMID 21555336 DOI: 10.1093/brain/awr089  0.96
2011 Bohnen NI, Albin RL. White matter lesions in Parkinson disease. Nature Reviews. Neurology. 7: 229-36. PMID 21343896 DOI: 10.1038/nrneurol.2011.21  0.96
2011 Garg SK, Vitvitsky V, Albin R, Banerjee R. Astrocytic redox remodeling by amyloid beta peptide Antioxidants and Redox Signaling. 14: 2385-2397. PMID 21235355 DOI: 10.1089/ars.2010.3681  0.96
2011 Chotinaiwattarakul W, Dayalu P, Chervin RD, Albin RL. Risk of sleep-disordered breathing in Parkinson's disease. Sleep & Breathing = Schlaf & Atmung. 15: 471-8. PMID 20473719 DOI: 10.1007/s11325-010-0362-3  0.96
2011 Bohnen NI, Albin RL. The cholinergic system and Parkinson disease. Behavioural Brain Research. 221: 564-73. PMID 20060022 DOI: 10.1016/j.bbr.2009.12.048  0.96
2010 Heng MY, Detloff PJ, Paulson HL, Albin RL. Early alterations of autophagy in Huntington disease-like mice. Autophagy. 6: 1206-8. PMID 20935460 DOI: 10.4161/auto.6.8.13617  0.96
2010 Tallaksen-Greene SJ, Janiszewska A, Benton K, Ruprecht L, Albin RL. Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease. Experimental Neurology. 225: 402-7. PMID 20659453 DOI: 10.1016/j.expneurol.2010.07.015  0.96
2010 Heng MY, Duong DK, Albin RL, Tallaksen-Greene SJ, Hunter JM, Lesort MJ, Osmand A, Paulson HL, Detloff PJ. Early autophagic response in a novel knock-in model of Huntington disease. Human Molecular Genetics. 19: 3702-20. PMID 20616151 DOI: 10.1093/hmg/ddq285  0.96
2010 Perry GM, Tallaksen-Greene S, Kumar A, Heng MY, Kneynsberg A, van Groen T, Detloff PJ, Albin RL, Lesort M. Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease. Human Molecular Genetics. 19: 3354-71. PMID 20558522 DOI: 10.1093/hmg/ddq247  0.96
2010 Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain : a Journal of Neurology. 133: 1747-54. PMID 20413575 DOI: 10.1093/brain/awq079  0.96
2010 Albin RL, Koeppe RA, Burke JF, Giordani B, Kilbourn MR, Gilman S, Frey KA. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment. Archives of Neurology. 67: 440-6. PMID 20385910 DOI: 10.1001/archneurol.2010.34  0.96
2010 Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, et al. Glycoproteomics in neurodegenerative diseases. Mass Spectrometry Reviews. 29: 79-125. PMID 19358229 DOI: 10.1002/mas.20221  0.96
2010 Bohnen NI, Müller MLTM, Kotagal V, Koeppe RA, Kilbourn MR, Albin RL, Frey KA. Reply: Cognition and olfaction in Parkinson's disease Brain. 133: e161. DOI: 10.1093/brain/awq228  0.96
2009 Bohnen NI, Müller ML, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, Albin RL. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology. 73: 1670-6. PMID 19917989 DOI: 10.1212/WNL.0b013e3181c1ded6  0.96
2009 Albin RL. The US health care system: Part 1: our current system. Neurology. 73: 571;author reply 571. PMID 19687461 DOI: 10.1212/WNL.0b013e3181af0a3a  0.96
2009 Bohnen NI, Albin RL. Cholinergic denervation occurs early in Parkinson disease. Neurology. 73: 256-7. PMID 19535769 DOI: 10.1212/WNL.0b013e3181b0bd3d  0.96
2009 Fink DJ, Albin RL. What sort of change to believe in: an alternate opinion. Annals of Neurology. 65: 619. PMID 19475662 DOI: 10.1002/ana.21669  0.96
2009 Tallaksen-Greene SJ, Janiszewska A, Benton K, Hou G, Dick R, Brewer GJ, Albin RL. Evaluation of tetrathiomolybdate in the R6/2 model of Huntington disease. Neuroscience Letters. 452: 60-2. PMID 19429000 DOI: 10.1016/j.neulet.2009.01.040  0.96
2009 Albin RL, Koeppe RA, Wernette K, Zhuang W, Nichols T, Kilbourn MR, Frey KA. Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome. Neurology. 72: 1390-6. PMID 19380698 DOI: 10.1212/WNL.0b013e3181a187dd  0.96
2009 Heng MY, Detloff PJ, Wang PL, Tsien JZ, Albin RL. In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 3200-5. PMID 19279257 DOI: 10.1523/JNEUROSCI.5599-08.2009  0.96
2008 Kitsou E, Pan S, Zhang J, Shi M, Zabeti A, Dickson DW, Albin R, Gearing M, Kashima DT, Wang Y, Beyer RP, Zhou Y, Pan C, Caudle WM, Zhang J. Identification of proteins in human substantia nigra. Proteomics. Clinical Applications. 2: 776-82. PMID 21136874 DOI: 10.1002/prca.200800028  0.96
2008 Albin RL, Koeppe RA, Rainier S, Fink JK. Normal dopaminergic nigrostriatal innervation in SPG3A hereditary spastic paraplegia. Journal of Neurogenetics. 22: 289-94. PMID 19085270 DOI: 10.1080/01677060802337307  0.96
2008 Mauldin PD, Guimaraes P, Albin RL, Ray Dorsey E, Bainbridge JL, Siderowf A. Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy. Clinical Therapeutics. 30: 1553-7. PMID 18803996 DOI: 10.1016/j.clinthera.2008.08.001  0.96
2008 Haut SR, Albin RL. Dopamine and epilepsy: hints of complex subcortical roles. Neurology. 71: 784-5. PMID 18779507 DOI: 10.1212/01.wnl.0000325637.38931.27  0.96
2008 Heng MY, Detloff PJ, Albin RL. Rodent genetic models of Huntington disease. Neurobiology of Disease. 32: 1-9. PMID 18638556 DOI: 10.1016/j.nbd.2008.06.005  0.96
2008 Albin RL, Joynt RJ. The case of the colorless crystals. Neurology. 70: 1055; author reply 1. PMID 18362289 DOI: 10.1212/01.wnl.0000311259.40672.3c  0.96
2008 Albin RL. Comment on Eskenazi et al. Medical Hypotheses. 71: 151-2. PMID 18329820 DOI: 10.1016/j.mehy.2008.01.022  0.96
2008 Shi M, Jin J, Wang Y, Beyer RP, Kitsou E, Albin RL, Gearing M, Pan C, Zhang J. Mortalin: a protein associated with progression of Parkinson disease? Journal of Neuropathology and Experimental Neurology. 67: 117-24. PMID 18219256 DOI: 10.1097/nen.0b013e318163354a  0.96
2008 Albin RL, Koeppe RA, Bohnen NI, Wernette K, Kilbourn MA, Frey KA. Spared caudal brainstem SERT binding in early Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 441-4. PMID 18073772 DOI: 10.1038/sj.jcbfm.9600599  0.96
2008 McKinney BC, Schneider JS, Schafer GL, Lowing JL, Mohan S, Zhao MX, Heng MY, Albin RL, Seasholtz AF, Akil H, Murphy GG. Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoter. Genes, Brain, and Behavior. 7: 203-13. PMID 17640289 DOI: 10.1111/j.1601-183X.2007.00339.x  0.96
2007 Heng MY, Tallaksen-Greene SJ, Detloff PJ, Albin RL. Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8989-98. PMID 17715336 DOI: 10.1523/JNEUROSCI.1830-07.2007  0.96
2007 Pan S, Shi M, Jin J, Albin RL, Lieberman A, Gearing M, Lin B, Pan C, Yan X, Kashima DT, Zhang J. Proteomics identification of proteins in human cortex using multidimensional separations and MALDI tandem mass spectrometer. Molecular & Cellular Proteomics : McP. 6: 1818-23. PMID 17644759 DOI: 10.1074/mcp.M700158-MCP200  0.96
2007 Albin RL. An advance in molecular imaging of dementias. The Lancet. Neurology. 6: 288-9. PMID 17362826 DOI: 10.1016/S1474-4422(07)70060-1  0.96
2006 Albin RL. Parkinson's disease: background, diagnosis, and initial management. Clinics in Geriatric Medicine. 22: 735-51, v. PMID 17000333 DOI: 10.1016/j.cger.2006.06.003  0.96
2006 Frey KA, Albin RL. Neuroimaging of Tourette syndrome. Journal of Child Neurology. 21: 672-7. PMID 16970868 DOI: 10.1177/08830738060210080501  0.96
2006 Albin RL. Practice Parameters for Parkinson disease: signposts for clinical research. Neurology. 66: 966-7. PMID 16606906 DOI: 10.1212/01.wnl.0000214662.19840.ea  0.96
2006 Albin RL. Neurobiology of basal ganglia and Tourette syndrome: striatal and dopamine function. Advances in Neurology. 99: 99-106. PMID 16536355  0.96
2006 Albin RL, Mink JW. Recent advances in Tourette syndrome research. Trends in Neurosciences. 29: 175-82. PMID 16430974 DOI: 10.1016/j.tins.2006.01.001  0.96
2006 Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 26: 1198-212. PMID 16421508 DOI: 10.1038/sj.jcbfm.9600276  0.96
2006 Yu Z, Dadgar N, Albertelli M, Scheller A, Albin RL, Robins DM, Lieberman AP. Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. The American Journal of Pathology. 168: 195-204. PMID 16400023 DOI: 10.2353/ajpath.2006.050619  0.96
2006 Albin RL, Barbas NR. Preface Clinics in Geriatric Medicine. 22: xi-xii. DOI: 10.1016/j.cger.2006.06.013  0.96
2005 Albin RL. Report from the neurology scientific integrity advisor: year 1. Neurology. 65: 781; author reply 78. PMID 16157929  0.96
2005 Albin RL. A new hypothesis for dystonia. Annals of Neurology. 58: 5-6. PMID 15984025 DOI: 10.1002/ana.20520  0.96
2005 Koeppe RA, Gilman S, Joshi A, Liu S, Little R, Junck L, Heumann M, Frey KA, Albin RL. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 936-44. PMID 15937303  0.96
2005 Philips ST, Albin RL, Martin DM. Genetics of subthalamic nucleus in development and disease. Experimental Neurology. 192: 320-30. PMID 15755549 DOI: 10.1016/j.expneurol.2004.11.008  0.96
2005 Tallaksen-Greene SJ, Crouse AB, Hunter JM, Detloff PJ, Albin RL. Neuronal intranuclear inclusions and neuropil aggregates in HdhCAG(150) knockin mice. Neuroscience. 131: 843-52. PMID 15749339 DOI: 10.1016/j.neuroscience.2004.10.037  0.96
2005 Albin RL. Sham surgery controls are mitigated trolleys. Journal of Medical Ethics. 31: 149-52. PMID 15738434 DOI: 10.1136/jme.2003.006155  0.96
2005 Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 64: 208-15. PMID 15668415 DOI: 10.1212/01.WNL.0000149403.14458.7F  0.96
2004 Deng YP, Albin RL, Penney JB, Young AB, Anderson KD, Reiner A. Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. Journal of Chemical Neuroanatomy. 27: 143-64. PMID 15183201 DOI: 10.1016/j.jchemneu.2004.02.005  0.96
2004 Lorincz MT, Detloff PJ, Albin RL, O'Shea KS. Embryonic stem cells expressing expanded CAG repeats undergo aberrant neuronal differentiation and have persistent Oct-4 and REST/NRSF expression. Molecular and Cellular Neurosciences. 26: 135-43. PMID 15121185 DOI: 10.1016/j.mcn.2004.01.016  0.96
2004 Montgomery EB, Pan T, Le W, Jankovic J, Ahlskog JE, Wooten GF, Albin RL, Frey KA. Slowing Parkinson's disease progression: Recent dopamine agonist trials [3] (multiple letters) Neurology. 62: 343-345.  0.96
2003 Albin RL. Genomic medicine. The New England Journal of Medicine. 349: 2170-1; author reply. PMID 14645650 DOI: 10.1056/NEJM200311273492219  0.96
2003 Montgomery EB. Agonists versus levodopa in PD: the thrilla of whitha. Neurology. 61: 1462; author reply 1. PMID 14638991  0.96
2003 Feeley Kearney JA, Albin RL. mGluRs: a target for pharmacotherapy in Parkinson disease. Experimental Neurology. 184: S30-6. PMID 14597323 DOI: 10.1016/S0014-4886(03)00391-1  0.96
2003 Gehring WJ, Bryck RL, Jonides J, Albin RL, Badre D. The mind's eye, looking inward? In search of executive control in internal attention shifting. Psychophysiology. 40: 572-85. PMID 14570165 DOI: 10.1111/1469-8986.00059  0.96
2003 Bomar JM, Benke PJ, Slattery EL, Puttagunta R, Taylor LP, Seong E, Nystuen A, Chen W, Albin RL, Patel PD, Kittles RA, Sheffield VC, Burmeister M. Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. Nature Genetics. 35: 264-9. PMID 14556008 DOI: 10.1038/ng1255  0.96
2003 Kemmerer ES, Desmond TJ, Albin RL, Kilbourn MR, Frey KA. Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole. Experimental Neurology. 183: 81-6. PMID 12957491 DOI: 10.1016/S0014-4886(03)00096-7  0.96
2003 Tallaksen-Greene SJ, Ordway JM, Crouse AB, Jackson WS, Detloff PJ, Albin RL. Hprt(CAG)146 mice: age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. The Journal of Comparative Neurology. 465: 205-19. PMID 12949782 DOI: 10.1002/cne.10855  0.96
2003 Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 61: 310-5. PMID 12913189  0.96
2003 Albin RL. Dominant ataxias and Friedreich ataxia: an update. Current Opinion in Neurology. 16: 507-14. PMID 12869811 DOI: 10.1097/01.wco.0000084230.82329.d5  0.96
2003 Jackson WS, Tallaksen-Greene SJ, Albin RL, Detloff PJ. Nucleocytoplasmic transport signals affect the age at onset of abnormalities in knock-in mice expressing polyglutamine within an ectopic protein context. Human Molecular Genetics. 12: 1621-9. PMID 12812988 DOI: 10.1093/hmg/ddg163  0.96
2003 Alb JG, Cortese JD, Phillips SE, Albin RL, Nagy TR, Hamilton BA, Bankaitis VA. Mice lacking phosphatidylinositol transfer protein-alpha exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia. The Journal of Biological Chemistry. 278: 33501-18. PMID 12788952 DOI: 10.1074/jbc.M303591200  0.96
2003 Albin RL, Cross D, Cornblath WT, Wald JA, Wernette K, Frey KA, Minoshima S. Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia. Annals of Neurology. 53: 528-32. PMID 12666122 DOI: 10.1002/ana.10527  0.96
2003 Albin RL, Frey KA. Initial agonist treatment of Parkinson disease: a critique. Neurology. 60: 390-4. PMID 12580185  0.96
2003 Albin RL. Neuroprotective agents for clinical trials in Parkinson's disease: A public policy experiment Neurology. 60: 1225.  0.96
2002 Minoshima S, Foster NL, Petrie EC, Albin RL, Frey KA, Kuhl DE. Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology. Journal of Geriatric Psychiatry and Neurology. 15: 200-9. PMID 12489916  0.96
2002 Albin RL. Fetal striatal transplantation in Huntington's disease: time for a pause. Journal of Neurology, Neurosurgery, and Psychiatry. 73: 612. PMID 12438457 DOI: 10.1136/jnnp.73.6.612  0.96
2002 Kearney JA, Buchner DA, De Haan G, Adamska M, Levin SI, Furay AR, Albin RL, Jones JM, Montal M, Stevens MJ, Sprunger LK, Meisler MH. Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6). Human Molecular Genetics. 11: 2765-75. PMID 12374766  0.96
2002 Albin RL. Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls. Journal of Medical Ethics. 28: 322-5. PMID 12356962 DOI: 10.1136/jme.28.5.322  0.96
2002 Albin RL, Nichols TE, Frey KA. Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease. Jama. 288: 311-2; author reply . PMID 12117386  0.96
2002 Suzuki M, Desmond TJ, Albin RL, Frey KA. Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias. Annals of Neurology. 51: 767-71. PMID 12112084 DOI: 10.1002/ana.10186  0.96
2002 Lavedan C, Buchholtz S, Nussbaum RL, Albin RL, Polymeropoulos MH. A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration. Neuroscience Letters. 322: 57-61. PMID 11958843 DOI: 10.1016/S0304-3940(01)02513-7  0.96
2002 Suzuki M, Desmond TJ, Albin RL, Frey KA. Cholinergic vesicular transporters in progressive supranuclear palsy. Neurology. 58: 1013-8. PMID 11940684  0.96
2001 Frey KA, Albin RL. Receptor binding techniques. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit1.4. PMID 18428450 DOI: 10.1002/0471142301.ns0104s00  0.96
2001 Albin RL. Samuel Adams' tremor. Neurology. 57: 1350. PMID 11591876  0.96
2001 Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Annals of Neurology. 50: 358-65. PMID 11558792 DOI: 10.1002/ana.1133  0.96
2001 Suzuki M, Desmond TJ, Albin RL, Frey KA. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Synapse (New York, N.Y.). 41: 329-36. PMID 11494403 DOI: 10.1002/syn.1089  0.96
2001 Albin RL. End of lines and boxes. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 405-6. PMID 11391733 DOI: 10.1002/mds.1086  0.96
2001 Kelly KM, Kume A, Albin RL, Macdonald RL. Autoradiography of L-type and N-type calcium channels in aged rat hippocampus, entorhinal cortex, and neocortex. Neurobiology of Aging. 22: 17-23. PMID 11164272 DOI: 10.1016/S0197-4580(00)00178-0  0.96
2001 Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Human Molecular Genetics. 10: 137-44. PMID 11152661  0.96
2000 Albin RL, Koeppe RA, Chervin RD, Consens FB, Wernette K, Frey KA, Aldrich MS. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology. 55: 1410-2. PMID 11087796  0.96
2000 Albin RL, Kearney JA. Alessandro Agnoli Lecture. Models of basal ganglia dysfunction: predictions and pitfalls. Functional Neurology. 15: 135-46. PMID 11062842  0.96
2000 Zhang C, Albin RL. Increased response to intrastriatal L(+)-2-amino-4-phosphonobutyrate (L-AP4) in unilateral 6-hydroxydopamine-lesioned rats. Experimental Neurology. 165: 278-84. PMID 10993688 DOI: 10.1006/exnr.2000.7452  0.96
2000 Albin RL. Basal ganglia neurotoxins. Neurologic Clinics. 18: 665-80. PMID 10873237  0.96
2000 Sullivan AA, Chervin RD, Albin RL. Parkinsonism after correction of hyponatremia with radiological central pontine myelinolysis and changes in the basal ganglia. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 7: 256-9. PMID 10833626 DOI: 10.1054/jocn.1999.0192  0.96
2000 Bohnen NI, Koeppe RA, Meyer P, Ficaro E, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Decreased striatal monoaminergic terminals in Huntington disease. Neurology. 54: 1753-9. PMID 10802780  0.96
2000 Kearney JA, Albin RL. Intrasubthalamic nucleus metabotropic glutamate receptor activation: a behavioral, Fos immunohistochemical and [14C]2-deoxyglucose autoradiographic study. Neuroscience. 95: 409-16. PMID 10658620 DOI: 10.1016/S0306-4522(99)00439-X  0.96
1999 Bazzett T, Legnard E, Bauter MR, Albin RL. Time-course analysis and comparison of acute and chronic intrastriatal quinolinic acid administration on forelimb reaching deficits in the rat. Experimental Neurology. 158: 126-34. PMID 10448424 DOI: 10.1006/exnr.1999.7070  0.96
1999 Meyer P, Bohnen NI, Minoshima S, Koeppe RA, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology. 53: 371-4. PMID 10430428  0.96
1999 Bohnen NI, Albin RL, Frey KA, Fink JK. (+)-alpha-[11C]Dihydrotetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis. Neurology. 52: 1067-9. PMID 10102431  0.96
1999 Sprunger LK, Escayg A, Tallaksen-Greene S, Albin RL, Meisler MH. Dystonia associated with mutation of the neuronal sodium channel Scn8a and identification of the modifier locus Scnm1 on mouse chromosome 3. Human Molecular Genetics. 8: 471-9. PMID 9949206  0.96
1999 Pennell PB, Burdette DE, Ross DA, Henry TR, Albin RL, Sackellares JC, Frey KA. Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis. Epilepsia. 40: 38-46. PMID 9924900 DOI: 10.1111/j.1528-1157.1999.tb01986.x  0.96
1998 Lavedan C, Buchholtz S, Auburger G, Albin RL, Athanassiadou A, Blancato J, Burguera JA, Ferrell RE, Kostic V, Leroy E, Leube B, Mota-Vieira L, Papapetropoulos T, Pericak-Vance MA, Pinkus J, et al. Absence of mutation in the beta- and gamma-synuclein genes in familial autosomal dominant Parkinson's disease. Dna Research : An International Journal For Rapid Publication of Reports On Genes and Genomes. 5: 401-2. PMID 10048491  0.96
1998 Savoiardo M, Albin RL. Cerebellar input tremor: Inferior or superior cerebellar peduncle lesion? [8] (multiple letters) Neurology. 51: 1777-1778. PMID 9855560  0.96
1998 Kearney JA, Becker JB, Frey KA, Albin RL. The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation. Neuroscience. 87: 881-91. PMID 9759976 DOI: 10.1016/S0306-4522(98)00193-6  0.96
1998 Albin RL. Fuch's corneal dystrophy in a patient with mitochondrial DNA mutations. Journal of Medical Genetics. 35: 258-9. PMID 9541117  0.96
1998 Shear DA, Dong J, Haik-Creguer KL, Bazzett TJ, Albin RL, Dunbar GL. Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task. Experimental Neurology. 150: 305-11. PMID 9527900 DOI: 10.1006/exnr.1998.6767  0.96
1998 Tallaksen-Greene SJ, Kaatz KW, Romano C, Albin RL. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Research. 780: 210-7. PMID 9507137 DOI: 10.1016/S0006-8993(97)01141-4  0.96
1998 Albin RL. Cerebellar input tremor. Neurology. 50: 307-8. PMID 9443505  0.96
1997 Ordway JM, Tallaksen-Greene S, Gutekunst CA, Bernstein EM, Cearley JA, Wiener HW, Dure LS, Lindsey R, Hersch SM, Jope RS, Albin RL, Detloff PJ. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell. 91: 753-63. PMID 9413985 DOI: 10.1016/S0092-8674(00)80464-X  0.96
1997 Fink JK, Hedera P, Mathay JG, Albin RL. Paroxysmal dystonic choreoathetosis linked to chromosome 2q: clinical analysis and proposed pathophysiology. Neurology. 49: 177-83. PMID 9222187  0.96
1997 Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 38: 797-802. PMID 9170449  0.52
1997 Kearney JA, Frey KA, Albin RL. Metabotropic glutamate agonist-induced rotation: a pharmacological, FOS immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 4415-25. PMID 9151758  0.96
1996 Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Annals of Neurology. 40: 873-84. PMID 9007092 DOI: 10.1002/ana.410400609  0.96
1996 Tallaksen-Greene SJ, Albin RL. Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons. Neuroscience. 75: 1057-64. PMID 8938741 DOI: 10.1016/0306-4522(96)00337-5  0.96
1996 Bazzett TJ, Falik RC, Becker JB, Albin RL. Chronic intrastriatal administration of quinolinic acid produces transient nocturnal hypermotility in the rat. Brain Research Bulletin. 39: 69-73. PMID 8846115 DOI: 10.1016/0361-9230(95)02043-8  0.96
1996 Kaatz KW, Albin RL. Intraseptal administration of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid induces immediate early gene expression in lateral septal neurons. Brain Research. 709: 205-14. PMID 8833756 DOI: 10.1016/0006-8993(95)01276-1  0.96
1996 Milbrandt JC, Albin RL, Turgeon SM, Caspary DM. GABAA receptor binding in the aging rat inferior colliculus. Neuroscience. 73: 449-58. PMID 8783261 DOI: 10.1016/0306-4522(96)00050-4  0.96
1996 Albin RL. The business of genomics. Nature Genetics. 14: 17. PMID 8782814 DOI: 10.1038/ng0996-17  0.96
1996 Bazzett TJ, Falik RC, Becker JB, Albin RL. Synergistic effects of chronic exposure to subthreshold concentrations of quinolinic acid and malonate in the rat striatum. Brain Research. 718: 228-32. PMID 8773793 DOI: 10.1016/0006-8993(96)00143-6  0.96
1996 Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA, Sima AA. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 47: 462-6. PMID 8757021  0.96
1996 Kume A, Greenfield LJ, Macdonald RL, Albin RL. Felbamate inhibits [3H]t-butylbicycloorthobenzoate (TBOB) binding and enhances Cl- current at the gamma-aminobutyric AcidA (GABAA) receptor. The Journal of Pharmacology and Experimental Therapeutics. 277: 1784-92. PMID 8667250  0.96
1995 Albin RL. The pathophysiology of chorea/ballism and Parkinsonism. Parkinsonism & Related Disorders. 1: 3-11. PMID 18590996  0.96
1995 Kearney JA, Albin RL. Adenosine A2 receptor-mediated modulation of contralateral rotation induced by metabotropic glutamate receptor activation. European Journal of Pharmacology. 287: 115-20. PMID 8749024 DOI: 10.1016/0014-2999(95)00479-3  0.96
1995 Albin RL. Selective neurodegeneration in Huntington's disease. Annals of Neurology. 38: 835-6. PMID 8526454 DOI: 10.1002/ana.410380602  0.96
1995 Burdette DE, Sakurai SY, Henry TR, Ross DA, Pennell PB, Frey KA, Sackellares JC, Albin RL. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology. 45: 934-41. PMID 7746410  0.96
1995 Kaatz KW, Albin RL. Intrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: a behavioral and Fos immunohistochemical study. Neuroscience. 66: 55-65. PMID 7637875 DOI: 10.1016/0306-4522(94)00568-P  0.96
1995 Snyder SE, Kume A, Jung YW, Connor SE, Sherman PS, Albin RL, Wieland DM, Kilbourn MR. Synthesis of carbon-11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3-dithianes and -dithiane oxides. Journal of Medicinal Chemistry. 38: 2663-71. PMID 7629805  0.96
1995 Galasso JM, Bazzett TJ, Becker JB, Albin RL. Synergistic effect of intrastriatal co-administration of L-NAME and quinolinic acid. Neuroreport. 6: 1505-8. PMID 7579135  0.96
1995 Bazzett TJ, Falik RC, Becker JB, Albin RL. Chronic administration of malonic acid produces selective neural degeneration and transient changes in calbindin immunoreactivity in rat striatum. Experimental Neurology. 134: 244-52. PMID 7556544 DOI: 10.1006/exnr.1995.1054  0.96
1995 Albin RL, Young AB, Penney JB. The functional anatomy of disorders of the basal ganglia. Trends in Neurosciences. 18: 63-4. PMID 7537410 DOI: 10.1016/0166-2236(95)80020-3  0.96
1995 Albin RL, Tagle DA. Genetics and molecular biology of Huntington's disease. Trends in Neurosciences. 18: 11-4. PMID 7535483 DOI: 10.1016/0166-2236(95)93943-R  0.96
1994 Kume A, Sakurai SY, Albin RL. Zinc inhibition of t-[3H]butylbicycloorthobenzoate binding to the GABAA receptor complex. Journal of Neurochemistry. 62: 602-7. PMID 8294923  0.96
1994 Koller WC, Busenbark K, Miner K. The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group. Annals of Neurology. 35: 717-23. PMID 8210229 DOI: 10.1002/ana.410350613  0.96
1994 Juiz JM, Albin RL, Helfert RH, Altschuler RA. Distribution of GABAA and GABAB binding sites in the cochlear nucleus of the guinea pig. Brain Research. 639: 193-201. PMID 8205472 DOI: 10.1016/0006-8993(94)91730-2  0.96
1994 Veenman CL, Albin RL, Richfield EK, Reiner A. Distributions of GABAA, GABAB, and benzodiazepine receptors in the forebrain and midbrain of pigeons. The Journal of Comparative Neurology. 344: 161-89. PMID 8077457 DOI: 10.1002/cne.903440202  0.96
1994 Albin RL, Howland MM, Higgins DS, Frey KA. Autoradiographic quantification of muscarinic cholinergic synaptic markers in bat, shrew, and rat brain. Neurochemical Research. 19: 581-9. PMID 8065514 DOI: 10.1007/BF00971334  0.96
1994 Sakurai SY, Kume A, Burdette DE, Albin RL. Quantitative autoradiography of [3H]t-butylbicycloorthobenzoate binding to the gamma-aminobutyric acid receptorA complex. The Journal of Pharmacology and Experimental Therapeutics. 270: 362-70. PMID 8035332  0.96
1994 Tallaksen-Greene SJ, Albin RL. Localization of AMPA-selective excitatory amino acid receptor subunits in identified populations of striatal neurons. Neuroscience. 61: 509-19. PMID 7969927 DOI: 10.1016/0306-4522(94)90430-8  0.96
1994 Turgeon SM, Albin RL. GABAB binding sites in early adult and aging rat brain. Neurobiology of Aging. 15: 705-11. PMID 7891825 DOI: 10.1016/0197-4580(94)90052-3  0.96
1994 Milbrandt JC, Albin RL, Caspary DM. Age-related decrease in GABAB receptor binding in the Fischer 344 rat inferior colliculus. Neurobiology of Aging. 15: 699-703. PMID 7891824 DOI: 10.1016/0197-4580(94)90051-5  0.96
1994 Aldrich MS, Prokopowicz G, Ockert K, Hollingsworth Z, Penney JB, Albin RL. Neurochemical studies of human narcolepsy: alpha-adrenergic receptor autoradiography of human narcoleptic brain and brainstem. Sleep. 17: 598-608. PMID 7846457  0.96
1994 Turgeon SM, Albin RL. Postnatal ontogeny of GABAB binding in rat brain. Neuroscience. 62: 601-13. PMID 7830900 DOI: 10.1016/0306-4522(94)90392-1  0.96
1994 Kume A, Albin RL. Quantitative autoradiography of 4'-ethynyl-4-n-[2,3-3H2]propylbicycloorthobenzoate binding to the GABAA receptor complex. European Journal of Pharmacology. 263: 163-73. PMID 7821348 DOI: 10.1016/0014-2999(94)90537-1  0.96
1994 Bazzett TJ, Becker JB, Falik RC, Albin RL. Chronic intrastriatal quinolinic acid produces reversible changes in perikaryal calbindin and parvalbumin immunoreactivity. Neuroscience. 60: 837-41. PMID 7523988 DOI: 10.1016/0306-4522(94)90266-6  0.96
1993 Turgeon SM, Albin RL. Pharmacology, distribution, cellular localization, and development of GABAB binding in rodent cerebellum. Neuroscience. 55: 311-23. PMID 8397345 DOI: 10.1016/0306-4522(93)90501-6  0.96
1993 Price RH, Albin RL, Sakurai SY, Polinsky RJ, Penney JB, Young AB. Cerebellar excitatory and inhibitory amino acid receptors in multiple system atrophy. Neurology. 43: 1323-8. PMID 8392149  0.96
1993 Bazzett TJ, Becker JB, Kaatz KW, Albin RL. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration. Experimental Neurology. 120: 177-85. PMID 8387931 DOI: 10.1006/exnr.1993.1053  0.96
1993 Jones JM, Albin RL, Feldman EL, Simin K, Schuster TG, Dunnick WA, Collins JT, Chrisp CE, Taylor BA, Meisler MH. mnd2: a new mouse model of inherited motor neuron disease. Genomics. 16: 669-77. PMID 8325640 DOI: 10.1006/geno.1993.1246  0.96
1993 Sakurai SY, Lutz PL, Schulman A, Albin RL. Unchanged [3H]MK-801 binding and increased [3H]flunitrazepam binding in turtle forebrain during anoxia. Brain Research. 625: 181-5. PMID 8275301 DOI: 10.1016/0006-8993(93)91057-Y  0.96
1993 Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, Swaroop M, Kaatz KW, Collins FS, Albin RL. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genetics. 5: 259-65. PMID 8275091 DOI: 10.1038/ng1193-259  0.96
1993 Kuriyama H, Albin RL, Altschuler RA. Expression of NMDA-receptor mRNA in the rat cochlea. Hearing Research. 69: 215-20. PMID 8226342 DOI: 10.1016/0378-5955(93)90110-M  0.96
1993 Albin RL. Antagonistic pleiotropy, mutation accumulation, and human genetic disease. Genetica. 91: 279-86. PMID 8125276 DOI: 10.1007/BF01436004  0.96
1993 Curran EJ, Albin RL, Becker JB. Adrenal medulla grafts in the hemiparkinsonian rat: profile of behavioral recovery predicts restoration of the symmetry between the two striata in measures of pre- and postsynaptic dopamine function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 3864-77. PMID 8103552  0.96
1993 Albin RL, Hollingsworth Z, Sakurai SY, Gilman S. Inhibitory and excitatory amino acid neurotransmitter binding sites in cynomolgus monkey (Macaca fascicularis) cervical spinal cord. Brain Research. 604: 354-7. PMID 8096159 DOI: 10.1016/0006-8993(93)90391-Y  0.96
1993 Kremer B, Tallaksen-Greene SJ, Albin RL. AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: implications for Huntington's disease. Neurology. 43: 1593-5. PMID 7688883  0.96
1992 Kincaid AE, Albin RL, Newman SW, Penney JB, Young AB. 6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons. Neuroscience. 51: 705-18. PMID 1488118 DOI: 10.1016/0306-4522(92)90309-P  0.96
1992 Turgeon SM, Albin RL. Zinc modulates GABAB binding in rat brain. Brain Research. 596: 30-4. PMID 1467992 DOI: 10.1016/0006-8993(92)91528-M  0.96
1992 Kaatz KW, Bazzett TJ, Albin RL. A new, simple myelin stain. Brain Research Bulletin. 29: 697-8. PMID 1384938 DOI: 10.1016/0361-9230(92)90141-J  0.96
1992 Albin RL, Reiner A, Anderson KD, Dure LS, Handelin B, Balfour R, Whetsell WO, Penney JB, Young AB. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Annals of Neurology. 31: 425-30. PMID 1375014 DOI: 10.1002/ana.410310412  0.96
1992 Albin RL, Gilman S. GABAA, GABAB, and benzodiazepine binding sites in the cerebellar cortex of the red-eared turtle (Pseudemys scripta). Brain Research. 595: 164-6. PMID 1334769 DOI: 10.1016/0006-8993(92)91469-U  0.96
1992 Tallaksen-Greene SJ, Wiley RG, Albin RL. Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons. Brain Research. 594: 165-70. PMID 1334764 DOI: 10.1016/0006-8993(92)91044-F  0.96
1992 Albin RL, Makowiec RL, Hollingsworth ZR, Dure LS, Penney JB, Young AB. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience. 46: 35-48. PMID 1317515 DOI: 10.1016/0306-4522(92)90006-N  0.96
1992 Albin RL, Greenamyre JT. Alternative excitotoxic hypotheses. Neurology. 42: 733-8. PMID 1314341  0.96
1991 Albin RL, Makowiec RL, Hollingsworth Z, Sakurai SY, Dure LS, Penney JB, Young AB. Excitatory amino acidergic pathways and receptors in the basal ganglia. Amino Acids. 1: 339-50. PMID 24194174 DOI: 10.1007/BF00814003  0.96
1991 Pranzatelli MR, Albin RL, Cohen BH. Acute dyskinesias in young asthmatics treated with theophylline. Pediatric Neurology. 7: 216-9. PMID 1878103 DOI: 10.1016/0887-8994(91)90088-3  0.96
1991 Bazzett TJ, Becker JB, Albin RL. A novel device for chronic intracranial drug delivery via microdialysis. Journal of Neuroscience Methods. 40: 1-8. PMID 1839046 DOI: 10.1016/0165-0270(91)90111-C  0.96
1991 Albin RL, Qin Y, Young AB, Penney JB, Chesselet MF. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study. Annals of Neurology. 30: 542-9. PMID 1838677 DOI: 10.1002/ana.410300406  0.96
1991 Albin RL, Price RH, Sakurai SY, Penney JB, Young AB. Excitatory and inhibitory amino acid binding sites in human dentate nucleus. Brain Research. 560: 350-3. PMID 1760743 DOI: 10.1016/0006-8993(91)91258-3  0.96
1991 Albin RL, Sakurai SY, Makowiec RL, Gilman S. Excitatory and inhibitory amino acid neurotransmitter binding sites in the cerebellar cortex of the pigeon (Columba livia). Journal of Chemical Neuroanatomy. 4: 429-37. PMID 1685884 DOI: 10.1016/0891-0618(91)90023-6  0.96
1991 Albin RL, Sakurai SY, Makowiec RL, Higgins DS, Young AB, Penney JB. Excitatory amino acid, GABA(A), and GABA(B) binding sites in human striate cortex. Cerebral Cortex (New York, N.Y. : 1991). 1: 499-509. PMID 1668367 DOI: 10.1093/cercor/1.6.499  0.96
1990 Albin RL. The death of Nicholas Bolkonski. Neurology in Tolstoy's War and Peace. Archives of Neurology. 47: 225-6. PMID 2302093 DOI: 10.1001/archneur.1990.00530020137029  0.96
1990 Albin RL, Makowiec RL, Hollingsworth Z, Dure LS, Penney JB, Young AB. Excitatory amino acid binding sites in the periaqueductal gray of the rat. Neuroscience Letters. 118: 112-5. PMID 2175406 DOI: 10.1016/0304-3940(90)90261-7  0.96
1990 Albin RL, Gilman S. Autoradiographic localization of inhibitory and excitatory amino acid neurotransmitter receptors in human normal and olivopontocerebellar atrophy cerebellar cortex. Brain Research. 522: 37-45. PMID 2171714 DOI: 10.1016/0006-8993(90)91574-Z  0.96
1990 Albin RL, Albers JW. Long-term follow-up of pyridoxine-induced acute sensory neuropathy-neuronopathy. Neurology. 40: 1319. PMID 2166252  0.96
1990 Chu DC, Albin RL, Young AB, Penney JB. Distribution and kinetics of GABAB binding sites in rat central nervous system: a quantitative autoradiographic study. Neuroscience. 34: 341-57. PMID 2159128 DOI: 10.1016/0306-4522(90)90144-S  0.96
1990 Makowiec RL, Albin RL, Cha JH, Young AB, Gilman S. Two types of quisqualate receptors are decreased in human olivopontocerebellar atrophy cerebellar cortex. Brain Research. 523: 309-12. PMID 1976026  0.96
1990 Albin RL, Reiner A, Anderson KD, Penney JB, Young AB. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Annals of Neurology. 27: 357-65. PMID 1972318 DOI: 10.1002/ana.410270403  0.96
1990 Albin RL, Young AB, Penney JB, Handelin B, Balfour R, Anderson KD, Markel DS, Tourtellotte WW, Reiner A. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. The New England Journal of Medicine. 322: 1293-8. PMID 1691447 DOI: 10.1056/NEJM199005033221807  0.96
1989 Albin RL, Aldridge JW, Young AB, Gilman S. Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity. Brain Research. 491: 185-8. PMID 2569908  0.96
1989 Albin RL, Gilman S. Parasagittal zonation of GABA-B receptors in molecular layer of rat cerebellum. European Journal of Pharmacology. 173: 113-4. PMID 2558028 DOI: 10.1016/0014-2999(89)90014-9  0.96
1989 Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends in Neurosciences. 12: 366-75. PMID 2479133 DOI: 10.1016/0166-2236(89)90074-X  0.96
1988 Albin RL, Young AB. Somatosensory phenomena in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 343-6. PMID 2974928 DOI: 10.1002/mds.870030411  0.96
1988 Greenamyre JT, Maragos WF, Albin RL, Penney JB, Young AB. Glutamate transmission and toxicity in Alzheimer's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 421-30. PMID 2900537 DOI: 10.1016/0278-5846(88)90102-9  0.96
1988 Albin RL, Bromberg MB, Penney JB, Knapp R. Chorea and dystonia: a remote effect of carcinoma. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 162-9. PMID 2851739 DOI: 10.1002/mds.870030208  0.96
1988 Albin RL, Young AB, Penney JB. Tetrahydro-9-aminoacridine (THA) interacts with the phencyclidine (PCP) receptor site. Neuroscience Letters. 88: 303-7. PMID 2838771 DOI: 10.1016/0304-3940(88)90228-5  0.96
1988 Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington disease. Proceedings of the National Academy of Sciences of the United States of America. 85: 5733-7. PMID 2456581  0.96
Show low-probability matches.